Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells
Marta Osrodek, 1 Michal Rozanski, 1, 2 Malgorzata Czyz 1 1Department of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland; 2Laboratory of Transcriptional Regulation, Institute of Medical Biology, Polish Academy of Sciences, Lodz, PolandCorrespondence: Malgorzata CzyzDepartment...
Main Authors: | Osrodek M, Rozanski M, Czyz M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-08-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/insulin-reduces-the-efficacy-of-vemurafenib-and-trametinib-in-melanoma-peer-reviewed-article-CMAR |
Similar Items
-
Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement
by: Xiaomeng Wang, et al.
Published: (2023-08-01) -
Vemurafenib resistant melanoma cells acquire mesenchymal stem cell-like properties
by: A. A. Vartanian, et al.
Published: (2019-12-01) -
Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro
by: Iris Car, et al.
Published: (2023-08-01) -
Differential impact of BRAFV600E isoforms on tumorigenesis in a zebrafish model of melanoma
by: Raffaella De Paolo, et al.
Published: (2023-07-01) -
Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib
by: Iris Car, et al.
Published: (2023-04-01)